---
pmid: '25574898'
title: Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms
  of childhood blindness.
authors:
- Kmoch S
- Majewski J
- Ramamurthy V
- Cao S
- Fahiminiya S
- Ren H
- MacDonald IM
- Lopez I
- Sun V
- Keser V
- Khan A
- Stránecký V
- Hartmannová H
- Přistoupilová A
- Hodaňová K
- Piherová L
- Kuchař L
- Baxová A
- Chen R
- Barsottini OG
- Pyle A
- Griffin H
- Splitt M
- Sallum J
- Tolmie JL
- Sampson JR
- Chinnery P
- Care4Rare Canada
- Banin E
- Sharon D
- Dutta S
- Grebler R
- Helfrich-Foerster C
- Pedroso JL
- Kretzschmar D
- Cayouette M
- Koenekoop RK
journal: Nat Commun
year: '2015'
full_text_available: false
pmcid: PMC4356490
doi: 10.1038/ncomms6614
---

# Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness.
**Authors:** Kmoch S, Majewski J, Ramamurthy V, Cao S, Fahiminiya S, Ren H, MacDonald IM, Lopez I, Sun V, Keser V, Khan A, Stránecký V, Hartmannová H, Přistoupilová A, Hodaňová K, Piherová L, Kuchař L, Baxová A, Chen R, Barsottini OG, Pyle A, Griffin H, Splitt M, Sallum J, Tolmie JL, Sampson JR, Chinnery P, Care4Rare Canada, Banin E, Sharon D, Dutta S, Grebler R, Helfrich-Foerster C, Pedroso JL, Kretzschmar D, Cayouette M, Koenekoop RK
**Journal:** Nat Commun (2015)
**DOI:** [10.1038/ncomms6614](https://doi.org/10.1038/ncomms6614)
**PMC:** [PMC4356490](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356490/)

## Abstract

1. Nat Commun. 2015 Jan 9;6:5614. doi: 10.1038/ncomms6614.

Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms 
of childhood blindness.

Kmoch S(1), Majewski J(2), Ramamurthy V(3), Cao S(4), Fahiminiya S(2), Ren H(4), 
MacDonald IM(5), Lopez I(4), Sun V(4), Keser V(4), Khan A(4), Stránecký V(1), 
Hartmannová H(1), Přistoupilová A(1), Hodaňová K(1), Piherová L(1), Kuchař L(1), 
Baxová A(6), Chen R(7), Barsottini OG(8), Pyle A(9), Griffin H(9), Splitt M(9), 
Sallum J(10), Tolmie JL(11), Sampson JR(12), Chinnery P(9); Care4Rare Canada; 
Banin E(15), Sharon D(15), Dutta S(16), Grebler R(17), Helfrich-Foerster C(17), 
Pedroso JL(8), Kretzschmar D(16), Cayouette M(18), Koenekoop RK(4).

Collaborators: Boycott K(13), MacKenzie A(13), Brudno M(14), Bulman D(13), 
Dyment D(13).

Author information:
(1)First Faculty of Medicine, Institute for Inherited Metabolic Disorders, 
Charles University in Prague, 120 00 Prague 2, Czech Republic.
(2)Faculty of Medicine, Department of Human Genetics, McGill University and 
Genome Quebec Innovation Center, Montreal, Quebec, Canada H3A 0G1.
(3)Cellular Neurobiology Research Unit, Institut de recherches cliniques de 
Montréal (IRCM), 110, Ave des Pins Ouest, Montreal, Quebec, Canada H2W 1R7.
(4)1] McGill University, 845 Sherbrooke Street West, Montreal, Quebec, Canada 
H3A 0G4 [2] McGill Ocular Genetics Laboratory; Departments of Paediatric 
Surgery, Human Genetics and Ophthalmology, Montreal Children's Hospital, McGill 
University Health Centre, 2300 Tupper, Montreal, Quebec, Canada H3H 1P3.
(5)Department of Ophthalmology and Visual Sciences, University of Alberta/Royal 
Alexandra Hospital, 10240 Kingsway Avenue, Edmonton, Alberta, Canada AB T5H 3V9.
(6)First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles 
University in Prague, 120 00 Prague 2, Czech Republic.
(7)Human Genome Sequencing Center, Department of Molecular and Human Genetics, 
Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
(8)Division of General Neurology and Ataxia Unit, Department of Neurology, 
Universidade Federal de São Paulo, Sao Paulo 04021-001, Brazil.
(9)Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 
3BZ, UK.
(10)Department of Ophthalmology, Universidade Federal de São Paulo, Sao Paulo 
04021-001, Brazil.
(11)Department of Clinical Genetics, Southern General Hospital, Glasgow G51 4TF, 
UK.
(12)Institute of Medical Genetics, Cardiff University School of Medicine, 
Cardiff CF14 4XN, UK.
(13)Children's Hospital of Eastern Ontario Research Institute, University of 
Ottawa, 401 Smyth Road, Ottawa, Ontario, Canada K1H 8L1.
(14)Department of Computer Science, University of Toronto, 10 King's College 
Road, Toronto, Ontario, Canada M5S 3G4.
(15)Department of Ophthalmology, Hadassah-Hebrew University Medical Center, 
Jerusalem 91120, Israel.
(16)Oregon Institute of Occupational Health Sciences, Oregon Health and Science 
University, Portland, Oregon 97239, USA.
(17)Lehrstuhl fuer Neurobiology und Genetik, Universitaet Wuerzburg, 97074 
Wuerzburg, Germany.
(18)1] Cellular Neurobiology Research Unit, Institut de recherches cliniques de 
Montréal (IRCM), 110, Ave des Pins Ouest, Montreal, Quebec, Canada H2W 1R7 [2] 
Departement de Médecine, Université de Montréal, Montreal, Quebec, Canada H3T 
1P1 [3] Division of Experimental Medicine, Department of Anatomy and Cell 
Biology, McGill University, Montreal, Quebec, Canada H3A 2B2.

Blindness due to retinal degeneration affects millions of people worldwide, but 
many disease-causing mutations remain unknown. PNPLA6 encodes the patatin-like 
phospholipase domain containing protein 6, also known as neuropathy target 
esterase (NTE), which is the target of toxic organophosphates that induce human 
paralysis due to severe axonopathy of large neurons. Mutations in PNPLA6 also 
cause human spastic paraplegia characterized by motor neuron degeneration. Here 
we identify PNPLA6 mutations in childhood blindness in seven families with 
retinal degeneration, including Leber congenital amaurosis and Oliver McFarlane 
syndrome. PNPLA6 localizes mostly at the inner segment plasma membrane in 
photoreceptors and mutations in Drosophila PNPLA6 lead to photoreceptor cell 
death. We also report that lysophosphatidylcholine and lysophosphatidic acid 
levels are elevated in mutant Drosophila. These findings show a role for PNPLA6 
in photoreceptor survival and identify phospholipid metabolism as a potential 
therapeutic target for some forms of blindness.

DOI: 10.1038/ncomms6614
PMCID: PMC4356490
PMID: 25574898 [Indexed for MEDLINE]

Conflict of interest statement: Competing financial interests: The authors 
declare no competing financial interests.
